Complications of the use of self-expanding metal stents as paliation of malignant obstruction of the gastric outlet tract

Authors

  • Ricardo Oliveros Instituto Nacional de Cancerología
  • Ana Bonilla Instituto Nacional de Cancerología
  • Ricardo Sánchez Instituto Nacional de Cancerología
  • Raúl Pinilla Instituto Nacional de Cancerología

DOI:

https://doi.org/10.35509/01239015.92

Keywords:

Gastric cancer, Gastric outlet obstructions, Pancreatic cancer, Stent

Abstract

The placement of self-expanding metallic stents (SEMS) is a common form of treatment in malignant obstructions to the gastric outlet tract, achieving the resolution of symptoms in the short term and with an acceptable risk of complications; It is convenient to know and the detail of its use and how to treat them. The objective of this publication was to evaluate the occurrence of complications of the procedure and its treatment.

Methods: The work had a descriptive component on the treatment of the use of prosthesis and its treatment and another of association with respect to the administration of oncological treatment with palliative intention and its result with respect to survival; In a retrospective manner, 150 patients were reviewed from January 2011 to 25July 2017, who required this procedure at the National Institute of Cancerology, in Bogotá, Colombia.

Results: A 64% (N = 96) of patients with stage IV disease were identified, which had an incidence of early complications of 11.33% (N = 17) and late complications 29.33% (N 29= 44). A technical success rate of 98.6% (148/150) and clinical success of 96% (146/150) was documented. Most of the complications were treated endoscopically and 2.66% (N = 4) patients needed surgical treatment.

Conclusions: Complications of duodenal stent placement can be successfully managed endoscopically in most cases. Patients who, in addition to prosthesis placement, received oncological treatment had a statistically significant higher survival rate.

References

Oliveros R, Sánchez R, Escobar R. Experiencia del Instituto Nacional de Cancerología en el manejo de obstrucción del tracto de salida gástrico y del colon con prótesis metálicas auto expandibles (PMAE). Rev Col Gastroenterol. 2014;29(1):19-25.

ASGE Standards of Practice Committee, Fukami N, Anderson MA, Khan K, Harrison ME, Appalaneni V, et al. The role of the endoscopy in the gastroduodenal obstruction. Gastrointest Endosc. 2011;74(1):13-21.

Instituto Nacional de Cancerología ESE. Análisis de la Situación del Cáncer en Colombia 2015. Primera edición. Bogotá, D. C.: Instituto Nacional de Cancerología ESE; 2017.

CANCER TODAY: International agency for research on cancer [internet]. Global cancer observatory; GLOBOCAN 2018. Consultado cáncer gástrico en América Latina, Colombia. Disponible en el siguiente URL: http://gco.iarc.fr/today/home

Oliveros R, Navarrera LF. Diagnóstico, estadificación y tratamiento del cáncer gástrico en Colombia desde 2004 a 2008 (REGATE-Colombia). Rev Col Gastroenterol. 2012;27(4):269-74.

Castaño R, Álvarez O, Lopera J, Ruiz M, Juliao F, Sanín E, et al. Endoprótesis metálicas autoexpandibles en la obstrucción maligna esofágica y gastroduodenal. Rev Colomb Cir. 2005;20(1):33-48.

Fiori E, Lamazza A, Volpino P, Burza A, Paparelli C, Cavallaro G, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004;24(1):269-71.

Brimhall B, Adler DG. Enteral stents for malignant gastric outlet obstruction. Gastrointest Endosc Clin N Am. 2011;21(3):389-403.

Jang JK, Song HY, Kim JH, Song M, Park JH, Kim EY. Tumor overgrowth after expandable metallic stent placement: experience in 583 patients with malignant gastroduodenal obstruction. AJR Am J Roentgenol. 2011;196(6):831-6.

Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol. 2002;97(1):72-8.

Costamagna G, Tringali A, Spicak J, Mutignani M, Shaw J, Roy A, et al. Treatment of malignant gastroduodenal obstruction with nitinol self-expanding metal stent: an international prospective multicenter registry. Digestive Liver Dis. 2012;44(1):37-43.

Leong T. Chemotherapy and radiotherapy in the management of gastric cancer. Curr Opin Gastroenterol. 2005;21(6):673-8.

Varadhachary G, Ajani JA. Gastric cancer. Clin Adv Hematol Oncol. 2005;3(2):118-24.

Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24(18):2903-9.

Tringali A, Didden P, Repici A, Spaander M, Bourke M, Williams SJ, et al. Endoscopic treatment of malingnant gastric and duodenal strictures: a prospective, multicenter study. Gastrointest Endosc. 2014;79(1):66-75.

Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857-72.

Dormann A, Meisner S, Verin N, Wenk Lang A. Self-expanding metal stents forgastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004;36(6):543-50.

Metha S, Hindmarsh A, Cheong E, Cockburn J, Saada J, Tighe R, et al. Prospective randomized trial of laparoscopic gastroyeyunostomy versus duodenal stenting for malignant gastric out flow obstruction. Surg Endosc. 2006;20(2):239-42.

Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, et al. Surgical gastroyeyunostomy or endoscopy stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010;71(3):490-9.

Baron TH. Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin N Am. 2007;17(1):83-104.

Zhou W, Yang Z. Stenting for malignant gastric outlet obstruction: Current status. Gastrointest Interv. 2014;3(2):65-8.

upper GI obstruction. Gastrointest Endosc. 2001;53(3):329-32.

Saleem A, Bakken J, Baron TH. Early massive bleeding after duodenal self-expandable metal stent placement for palliation of malignant gastric outlet obstruction. Gastrointest Endosc. 2011;74(6):1426-7.

Kang M, Song HY, Kim JW, Kim JH, Park JH, Na HK. Additional gastroduodenal stent placement: retrospective evaluation of 68 consecutive patients with malignant gastroduodenal obstruction. Acta Radiol. 2013;54(8):944-8.

Yim HB, Jacobson BC, Saltzman JR, Johannes RS, Bounds BC, Lee JH, et al. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc. 2001;53:329–332.

How to Cite

[1]
Oliveros, R. et al. 2019. Complications of the use of self-expanding metal stents as paliation of malignant obstruction of the gastric outlet tract. Revista Colombiana de Cancerología. 23, 3 (Sep. 2019), 74–81. DOI:https://doi.org/10.35509/01239015.92.

Downloads

Download data is not yet available.

Published

2019-09-29

Issue

Section

Research/original articles